Clinical trial
An Open-Label, Prospective, Single-Center, Randomized Controlled Trial Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study
NCT06794801 is registered in ClinicalTrials.gov with LanZhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Prospective, Single-Center, Randomized Controlled Trial Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study
- Lead sponsor
- LanZhou University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 31, 2025
- Completion date
- December 31, 2030
- Enrollment
- 134 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
st segment elevation myocardial infarction (stemi)